248 related articles for article (PubMed ID: 4611534)
1. Neuraminidase treated cells and their role in cancer immunotherapy.
Simmons RL; Rios A
Birth Defects Orig Artic Ser; 1973 Mar; 9(2):223-8. PubMed ID: 4611534
[No Abstract] [Full Text] [Related]
2. Neuraminidase and concanavalin A in the experimental immunotherapy of cancer.
Simmons RL; Rios A
Johns Hopkins Med J Suppl; 1974; 3():75-84. PubMed ID: 4536589
[No Abstract] [Full Text] [Related]
3. Comparative immunotherapeutic effect of concanavalin A and neuraminidase-treated cancer cells.
Simmons RL; Rios A
Transplant Proc; 1975 Jun; 7(2):247-51. PubMed ID: 1129845
[No Abstract] [Full Text] [Related]
4. Comparative effect of Mycobacterium bovis- and neuraminidase-treated tumor cells on the growth of established methylcholanthrene fibrosarcomas in syngeneic mice.
Rios A; Simmons RL
Cancer Res; 1972 Jan; 32(1):16-21. PubMed ID: 4550256
[No Abstract] [Full Text] [Related]
5. Comparative and combined effect of BCG and neuraminidase in experimental immunotherapy.
Simmons RL; Rios A
Natl Cancer Inst Monogr; 1973 Dec; 39():57-68. PubMed ID: 4595327
[No Abstract] [Full Text] [Related]
6. Immunospecific regression of methylcholanthrene fibrosarcoma using neuraminidase. 3. Synergistic effect of BCG and neuraminidase treated tumor cells.
Simmons RL; Rios A
Ann Surg; 1972 Aug; 176(2):188-94. PubMed ID: 4562008
[No Abstract] [Full Text] [Related]
7. Experimental and clinical trials with BCG immunotherapy.
Sparks FC; Silverstein MJ; Hunt JS; O'Connell TX; Lee YT; Pilch YH; Haskell CM; Morton DL
Johns Hopkins Med J Suppl; 1974; 3():103-20. PubMed ID: 4609024
[No Abstract] [Full Text] [Related]
8. Immunotherapy with neuraminidase-treated tumor cells after radiotherapy.
Song CW; Levitt SH
Radiat Res; 1975 Dec; 64(3):485-91. PubMed ID: 1197655
[No Abstract] [Full Text] [Related]
9. Experimental cancer immunotherapy using a neuraminidase-treated non-viable frozen tumor vaccine.
Rios A; Simmons RL
Surgery; 1974 Apr; 75(4):503-7. PubMed ID: 4840798
[No Abstract] [Full Text] [Related]
10. Active specific immunotherapy of minimal residual tumor: excision plus neuraminidase-treated tumor cells.
Rios A; Simmons RL
Int J Cancer; 1974 Jan; 13(1):71-81. PubMed ID: 4818273
[No Abstract] [Full Text] [Related]
11. Differential effect of neuraminidase on the immunogenicity of viral associated and private antigens of mammary carcinomas.
Simmons RL; Rios A
J Immunol; 1973 Dec; 111(6):1820-5. PubMed ID: 4750868
[No Abstract] [Full Text] [Related]
12. Failure of immunotherapy with neuraminidase-treated tumor cell vaccine in mice bearing established 3-methylcholanthrene-induced sarcomas.
Spence RJ; Simon RM; Baker AR
J Natl Cancer Inst; 1978 Feb; 60(2):451-9. PubMed ID: 621758
[TBL] [Abstract][Full Text] [Related]
13. Effect of neuraminidase on growth of a 3-methylcholanthrene-induced fibrosarcoma in normal and immunosuppressed syngeneic mice.
Simmons RL; Rios A; Ray PK; Lundgren G
J Natl Cancer Inst; 1971 Nov; 47(5):1087-94. PubMed ID: 5123336
[No Abstract] [Full Text] [Related]
14. Radiation therapy and immunotherapy: the value of immunotherapy in the control of local and regional cancer.
Cancer; 1976 Apr; 37(4 Suppl):2108-19. PubMed ID: 769945
[No Abstract] [Full Text] [Related]
15. Immunoprophylaxis of syngeneic methycholanthrene-induced murine sarcomas with Bacillus Calmette-Guérin and tumor cells.
Zbar B; Canti G; Rapp HJ; Ashley MP; Sukumar S; Bast RC
Cancer Res; 1980 Apr; 40(4):1036-42. PubMed ID: 7357533
[No Abstract] [Full Text] [Related]
16. Effect of inoculation with neuraminidase-treated tumor cells on macrophage cytotoxicity in vitro.
Alley CD; Snodgrass MJ
Cancer Res; 1978 Aug; 38(8):2332-8. PubMed ID: 667829
[No Abstract] [Full Text] [Related]
17. Modified tumor cells in the immunotherapy of solid mammary tumors.
Simmons RL; Rios A; Trites P
Med Clin North Am; 1976 May; 60(3):551-65. PubMed ID: 1271892
[No Abstract] [Full Text] [Related]
18. Cell surface modification in the treatment of experimental cancer: neuraminidase or concanavalin A.
Simmons RL; Rios A
Cancer; 1974 Oct; 34(4 Suppl):suppl:1541-7. PubMed ID: 4138077
[No Abstract] [Full Text] [Related]
19. Immunospecific regression of various syngeneic mouse tumors in response to neuraminidase-treated tumor cells.
Rios A; Simmons RL
J Natl Cancer Inst; 1973 Aug; 51(2):637-44. PubMed ID: 4765377
[No Abstract] [Full Text] [Related]
20. The development of cellular immunity to tumor cells.
Cerilli J; Smith MC
Surg Gynecol Obstet; 1972 May; 134(5):739-45. PubMed ID: 5064081
[No Abstract] [Full Text] [Related]
[Next] [New Search]